FDA approves ADHD drug for binge-eating disorder

Federal health regulators have approved an attention deficit disorder drug for a new use: A first-of-its kind treatment for binge-eating disorder.

The Food and Drug Administration first approved Vyvanse as a once-a-day pill for hyperactivity disorder in 2007. On Friday the agency cleared the drug for adults who compulsively overeat.

Regulators approved the new use based on two studies in which adults with a history of had fewer instances per week while taking Vyvanse, compared with those getting a placebo.

Side effects of the drug, made by Shire PLC, can include psychiatric problems like hallucinations and mania as well as heart complications.

Shire PLC is an Irish-headquartered company based on the island of Jersey.

Explore further

Shire to buy specialty drugmaker NPS Pharma for $5.2 billion

© 2015 The Associated Press. All rights reserved.

Citation: FDA approves ADHD drug for binge-eating disorder (2015, January 30) retrieved 28 November 2020 from https://medicalxpress.com/news/2015-01-fda-adhd-drug-binge-eating-disorder.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments